P2P Syncro is at the forefront of rare disease education. We recognized that the educational approach used in disorders commonly seen may not apply to rare diseases. We adopted innovative strategies in conducting campaigns and delivering programs to physicians. In 2021, we became the first to demonstrate the impact of a rare disease education using real-world data. Over the years, we collaborated with numerous patient advocacy organizations. Our industry partners are those with a mission of improving the lives of patients with rare diseases.